{"id":1463,"date":"2021-07-08T10:45:35","date_gmt":"2021-07-08T07:45:35","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=1463"},"modified":"2021-07-08T10:47:07","modified_gmt":"2021-07-08T07:47:07","slug":"bms-atama-3","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=1463","title":{"rendered":"BMS T\u00fcrkiye\u2019den \u0130svi\u00e7re\u2019ye Atama"},"content":{"rendered":"

\"\"BMS yurt i\u00e7inde ve yurt d\u0131\u015f\u0131nda sundu\u011fu kariyer f\u0131rsatlar\u0131yla \u00e7al\u0131\u015fanlar\u0131n\u0131n geli\u015fimlerine \u00f6nemli katk\u0131lar sa\u011flamaya devam ediyor.<\/strong> BMS T\u00fcrkiye K\u0131demli Hasta G\u00fcvenli\u011fi M\u00fcd\u00fcr\u00fc Fulya Yasan, BMS \u0130svi\u00e7re ofisinde g\u00f6rev yapmak \u00fczere farmakovijilans ve ya\u015fam d\u00f6ng\u00fcs\u00fc y\u00f6netimi kalite yard\u0131mc\u0131 direkt\u00f6r\u00fc olarak atand\u0131<\/strong><\/p>\n

T\u00fcm d\u00fcnyada yenilik\u00e7i ila\u00e7lar\u0131 geli\u015ftirerek pazara sunan lider biyofarma \u015firketi Bristol Myers Squibb T\u00fcrkiye K\u0131demli Hasta G\u00fcvenli\u011fi M\u00fcd\u00fcr\u00fc Fulya Yasan, 1 Temmuz itibar\u0131yla \u0130svi\u00e7re ofisinde farmakovijilans ve ya\u015fam d\u00f6ng\u00fcs\u00fc y\u00f6netimi kalite yard\u0131mc\u0131 direkt\u00f6r\u00fc olarak g\u00f6rev yapmaya ba\u015flayacak.<\/p>\n

Fulya Yasan yeni g\u00f6revinde klinik g\u00fcvenlilik\/farmakovijilans, ruhsatland\u0131rma ve medikal i\u015fler faaliyetlerine ili\u015fkin kalite y\u00f6netim sisteminin kontrollerini sa\u011flaman\u0131n yan\u0131 s\u0131ra sa\u011fl\u0131k otoritesi farmakovijilans denetimlerini desteklemek ve y\u00f6netmekten sorumlu olacak.<\/p>\n

\u0130stanbul \u00dcniversitesi Eczac\u0131l\u0131k Fak\u00fcltesi’nden mezun olan ve Farmakoloji Anabilim Dal\u0131’nda y\u00fcksek lisans yapan Fulya Yasan Mart 2018’de BMS T\u00fcrkiye\u2019ye \u00fclke farmakovijilans m\u00fcd\u00fcr\u00fc olarak kat\u0131ld\u0131.<\/p>\n

BMS\u2019e kat\u0131lmadan \u00f6nce 7 y\u0131la yak\u0131n bir s\u00fcre Celgene \u0130la\u00e7 G\u00fcvenlili\u011fi ve Risk Y\u00f6netimi Uluslararas\u0131 Ekibi\u2019nin \u00fcyesi olan Fulya Yasan, bir\u00e7ok risk y\u00f6netim s\u00fcrecinde aktif rol oynad\u0131. 12 y\u0131l\u0131 a\u015fk\u0131n sekt\u00f6r tecr\u00fcbesi bulunan ve ba\u015far\u0131l\u0131 i\u015flerde g\u00f6rev alan Yasan, 2015 ve 2017 y\u0131llar\u0131nda Celgene Global \u0130la\u00e7 G\u00fcvenlili\u011fi ve Risk Y\u00f6netimi \u00dclke M\u00fckemmellik \u00d6d\u00fclleri ile 2016 y\u0131l\u0131nda Hasta Risk Y\u00f6netiminde M\u00fckemmellik \u00d6d\u00fcl\u00fc’n\u00fc ald\u0131. Ayn\u0131 zamanda BMS\u2019in, i\u015f yerinde \u00e7e\u015fitlili\u011fi ve dahiliyeti \u00f6n plana \u00e7\u0131kararak kad\u0131nlar\u0131n ger\u00e7ek potansiyellerine ula\u015fmalar\u0131na y\u00f6nelik \u00e7al\u0131\u015fmalar\u0131n\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fc B-NOW CEETII ekibinde proje liderli\u011fi ve T\u00fcrkiye B-NOW ekip liderli\u011fi g\u00f6revlerini \u00fcstlendi. B-NOW misyonunu desteklemek i\u00e7in b\u00f6lgesel ve yerel faaliyetlerin uygulanmas\u0131nda aktif \u00e7al\u0131\u015fmalarda bulundu.<\/p>\n","protected":false},"excerpt":{"rendered":"

BMS yurt i\u00e7inde ve yurt d\u0131\u015f\u0131nda sundu\u011fu kariyer f\u0131rsatlar\u0131yla \u00e7al\u0131\u015fanlar\u0131n\u0131n geli\u015fimlerine \u00f6nemli katk\u0131lar sa\u011flamaya devam ediyor. BMS T\u00fcrkiye K\u0131demli Hasta G\u00fcvenli\u011fi M\u00fcd\u00fcr\u00fc Fulya Yasan, BMS \u0130svi\u00e7re ofisinde g\u00f6rev yapmak \u00fczere farmakovijilans ve ya\u015fam d\u00f6ng\u00fcs\u00fc y\u00f6netimi kalite yard\u0131mc\u0131 direkt\u00f6r\u00fc olarak atand\u0131 T\u00fcm d\u00fcnyada yenilik\u00e7i ila\u00e7lar\u0131 geli\u015ftirerek pazara sunan lider biyofarma \u015firketi Bristol Myers Squibb T\u00fcrkiye K\u0131demli …<\/p>\n","protected":false},"author":1,"featured_media":1466,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/1463"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1463"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/1463\/revisions"}],"predecessor-version":[{"id":1467,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/1463\/revisions\/1467"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/1466"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}